title: Molecular dynamics of CYP2D6 polymorphisms in the absence and presence of a mechanism-based inactivator reveals changes in local flexibility and dominant substrate access channels.
abstract: Cytochrome P450 enzymes (CYPs) represent an important enzyme superfamily involved in metabolism of many endogenous and exogenous small molecules. CYP2D6 is responsible for ∼ 15% of CYP-mediated drug metabolism and exhibits large phenotypic diversity within CYPs with over 100 different allelic variants. Many of these variants lead to functional changes in enzyme activity and substrate selectivity. Herein, a molecular dynamics comparative analysis of four different variants of CYP2D6 was performed. The comparative analysis included simulations with and without SCH 66712, a ligand that is also a mechanism-based inactivator, in order to investigate the possible structural basis of CYP2D6 inactivation. Analysis of protein stability highlighted significantly altered flexibility in both proximal and distal residues from the variant residues. In the absence of SCH 66712, *34, *17-2, and *17-3 displayed more flexibility than *1, and *53 displayed more rigidity. SCH 66712 binding reversed flexibility in *17-2 and *17-3, through *53 remained largely rigid. Throughout simulations with docked SCH 66712, ligand orientation within the heme-binding pocket was consistent with previously identified sites of metabolism and measured binding energies. Subsequent tunnel analysis of substrate access, egress, and solvent channels displayed varied bottle-neck radii. Taken together, our results indicate that SCH 66712 should inactivate these allelic variants, although varied flexibility and substrate binding-pocket accessibility may alter its interaction abilities.
authors.affiliation: Department of Chemistry, Kalamazoo College, Kalamazoo, Michigan, United States of America.
authors.forename: Parker W
authors.initials: PW
authors.lastname: de Waal
authors.affiliation: Department of Chemistry, Kalamazoo College, Kalamazoo, Michigan, United States of America.
authors.forename: Kyle F
authors.initials: KF
authors.lastname: Sunden
authors.affiliation: Department of Chemistry, Kalamazoo College, Kalamazoo, Michigan, United States of America.
authors.forename: Laura Lowe
authors.initials: LL
authors.lastname: Furge
mesh_terms: D000483:Alleles; D018360:Crystallography, X-Ray; D019389:Cytochrome P-450 CYP2D6 / Q000737:chemistry* / Q000235:genetics*; D007093:Imidazoles / Q000737:chemistry / Q000494:pharmacology*; D008024:Ligands; D062105:Molecular Docking Simulation; D056004:Molecular Dynamics Simulation; D050505:Mutant Proteins / Q000737:chemistry / Q000378:metabolism; D011110:Polymorphism, Genetic; D011743:Pyrimidines / Q000737:chemistry / Q000494:pharmacology*; D013379:Substrate Specificity / Q000187:drug effects; D013816:Thermodynamics; D013997:Time Factors
chemical_list: D007093:Imidazoles; D008024:Ligands; D050505:Mutant Proteins; D011743:Pyrimidines; C403229:SCH 66712; D019389:Cytochrome P-450 CYP2D6